Elliot Stokes, PA
Physician Assistant · Suwanee, GANPI 1689128902
Payments from drug & device makers
Across 109 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$503
- Johnson & Johnson$277
- Regeneron Healthcare Solutions, Inc.$264
- LEO Pharma Inc.$218
- Pfizer$152
- Boehringer Ingelheim$131
- plus $764 from 15 others
What the payments were for
- Food & beverage$2,21996%
- Education$904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $503 |
| Johnson & Johnson | 11 | $277 |
| Regeneron Healthcare Solutions, Inc. | 9 | $264 |
| LEO Pharma Inc. | 12 | $218 |
| Pfizer | 7 | $152 |
| Boehringer Ingelheim | 5 | $131 |
| Amgen | 5 | $113 |
| Arcutis Biotherapeutics, Inc. | 5 | $98 |
| Incyte Corporation | 4 | $87 |
| Galderma Laboratories, L.p. | 5 | $86 |
| Journey Medical Corporation | 2 | $62 |
| Genentech USA, Inc. | 5 | $57 |
| Sun Pharmaceutical Industries Inc. | 3 | $53 |
| UCB, Inc. | 2 | $50 |
| Sanofi | 1 | $35 |
| Botanix SB Inc | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Organon | 2 | $19 |
| LNHC, Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
$2,309 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $230,635 |
| Dupixent PenDupilumab | 12 | $44,342 |
| Ketoconazole | 97 | $1,253 |
| Triamcinolone Acetonide | 81 | $712 |
| CiclopiroxCiclopirox Olamine | 42 | $662 |
| Metronidazole | 12 | $553 |
| Betamethasone Dipropionate | 20 | $534 |
| Clobetasol Propionate | 14 | $247 |
| Cephalexin | 30 | $225 |
| Hydrocortisone | 33 | $151 |
| Mupirocin | 13 | $108 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Suwanee
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.